Blog

HUL Share Price Falls 4% After Q2 Results: What Do Analysts Say?

HUL Share Price Falls 4% After Q2 Results: What Do Analysts Say? Hindustan Unilever Ltd. shares declined as much as nearly 5% during trade so far, after the company posted its second quarter results early Thursday. The decline in share price came despite a largely positive consensus among top brokerages, who have maintained their ‘buy’

Blog

Laurus Labs Q2 Results: Decoding the Surge in Net Profit and Its Impact on Investors

Laurus Labs Q2 Results: A Comprehensive Analysis Laurus Labs Ltd. shares declined over 3% on Friday, a day after the company reported strong second-quarter earnings. The decline comes despite the pharmaceutical firm posting a robust performance for the July–September period, with consolidated revenue rising 35.1% year-on-year to Rs 1,653.47 crore and net profit surging 883%

Blog

HUL Q2 Review: Systematix Maintains ‘Hold’ Rating, Hikes Target Price — What Indian Investors Need to Know

HUL Q2 Review: A Comprehensive Analysis for Indian Investors Indian investors and traders are keenly watching the developments in the stock market, and one of the most significant recent events was the Q2 review of Hindustan Unilever Ltd. (HUL) by Systematix. In this review, Systematix maintained a ‘hold’ rating for HUL but hiked its target

Blog

SEBI Cracks Down on Front-Running: 13 Individuals and HUFs Barred

SEBI Cracks Down on Front-Running: 13 Individuals and HUFs Barred The Securities and Exchange Board of India (SEBI) has barred 13 individuals and Hindu Undivided Families (HUFs) from the stock market for periods ranging from one to three years in a case of alleged front-running involving 30 noticees. The regulator found that orders were placed

Blog

Q2 Results Live: Top Companies to Declare Earnings Today

Q2 Earnings Season: What to Expect from Top Companies The Indian stock market is bracing for a busy day of earnings reports, with over 20 companies scheduled to declare their Q2FY26 results. Among the major companies announcing their results today are Dr Reddy’s Labs, SBI Life, and Coforge. In this article, we’ll take a closer

Blog

Kotak Securities Rejects ‘Equities Vs Gold’ Debate: Why You Should Consider Both

Kotak Securities Rejects ‘Equities Vs Gold’ Debate: Why You Should Consider Both The traditional ‘Equities vs. Gold’ debate is largely irrelevant, according to Kotak Securities, as the assets serve fundamentally different functions in household savings. Equities for Investment, Gold for Insurance Kotak Securities, in a recent note, said that equities are for investment and while

Scroll to Top